Portugal’s economic growth is expected to slow through this year and next, as the country struggles with a systemic banking crisis, the lack of a convincing medium-term fiscal plan and excessive public and private sector leverage.
Growth is expected to decline, suffering the effects of the Brexit outcome, with investment and private consumption to slow materially, pushing 2016 growth down to 0.7 percent and 2017 to 0.3 percent, Barclays reported.
Further, the total capital needs for the Portuguese banks is expected at EUR7.5 billion. This includes EUR5 billion for Caixa Geral and potentially EUR2.5 billion for BCP if it cannot meet higher requirements independently. However, this does not take into account the positive effect of the repayment of the contingent convertibles (CoCos) of both banks, the report mentioned.
Further, Barclays said that it expects public debt to increase from 130 percent of GDP in 2015 to 132 percent in 2016 and remain above 130 percent through 2020. The government is expected to achieve a primary fiscal balance slightly above 1 percent of GDP over the medium term.
"More importantly, the government has yet to formulate a realistic medium-term fiscal path consistent with solvency, in our view," Barclays commented in its report.
Meanwhile, no major risks have emerged in Italy and Spain that could possibly spread to Portugal. However, any negative shocks to the risk factors could see sufficient pressure on Portugal’s finances for it to consider another program. In such a downside scenario, more debt relief might be needed to ensure fiscal solvency.


Best Gold Stocks to Buy Now: AABB, GOLD, GDX
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
FxWirePro: Daily Commodity Tracker - 21st March, 2022 



